The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet. The ...
The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.
The FDA approved Astellas' gastric cancer therapy. CVS Health CEO Karen Lynch steps down amid shareholder pressure, with ...
CVS Health tapped industry executive David Joyner to replace CEO Karen Lynch and turn around the struggling business. Joyner ...
CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch at the ...
America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...
Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...